---
schema_version: "secwatch.filing_event.v1"
accession: "0001453687-25-000054"
form_type: "8-K"
ticker: "RNAC"
cik: "0001453687"
company_name: "Cartesian Therapeutics, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T17:25:02.922990+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Cartesian Therapeutics files 8-K with corporate slide deck; no material news evident

## Summary
- Slide deck titled 'Pioneering mRNA Cell Therapy for Autoimmunity' dated March 2025 furnished as Exhibit 99.1.
- No financial results, pipeline updates, or guidance changes provided in the filing.
- The exhibit is furnished under Regulation FD and contains no new material information.

## SEC filing metadata
- accession: 0001453687-25-000054
- form_type: 8-K
- ticker: RNAC
- cik: 0001453687
- company_name: Cartesian Therapeutics, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.0
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/0001453687-25-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/rnac-20250303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001453687-25-000054
- JSON: https://secwatch.observer/filing/0001453687-25-000054.json
- Plain text: https://secwatch.observer/filing/0001453687-25-000054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.